Cargando…
miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation
BACKGROUND: Myogenesis is driven by specific changes in the transcriptome that occur during the different stages of muscle differentiation. In addition to controlled transcriptional transitions, several other post-transcriptional mechanisms direct muscle differentiation. Both alternative splicing an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888935/ https://www.ncbi.nlm.nih.gov/pubmed/31791406 http://dx.doi.org/10.1186/s13395-019-0211-4 |
_version_ | 1783475329358102528 |
---|---|
author | Bjorkman, Kristen K. Buvoli, Massimo Pugach, Emily K. Polmear, Michael M. Leinwand, Leslie A. |
author_facet | Bjorkman, Kristen K. Buvoli, Massimo Pugach, Emily K. Polmear, Michael M. Leinwand, Leslie A. |
author_sort | Bjorkman, Kristen K. |
collection | PubMed |
description | BACKGROUND: Myogenesis is driven by specific changes in the transcriptome that occur during the different stages of muscle differentiation. In addition to controlled transcriptional transitions, several other post-transcriptional mechanisms direct muscle differentiation. Both alternative splicing and miRNA activity regulate gene expression and production of specialized protein isoforms. Importantly, disruption of either process often results in severe phenotypes as reported for several muscle diseases. Thus, broadening our understanding of the post-transcriptional pathways that operate in muscles will lay the foundation for future therapeutic interventions. METHODS: We employed bioinformatics analysis in concert with the well-established C2C12 cell system for predicting and validating novel miR-1 and miR-206 targets engaged in muscle differentiation. We used reporter gene assays to test direct miRNA targeting and studied C2C12 cells stably expressing one of the cDNA candidates fused to a heterologous, miRNA-resistant 3′ UTR. We monitored effects on differentiation by measuring fusion index, myotube area, and myogenic gene expression during time course differentiation experiments. RESULTS: Gene ontology analysis revealed a strongly enriched set of putative miR-1 and miR-206 targets associated with RNA metabolism. Notably, the expression levels of several candidates decreased during C2C12 differentiation. We discovered that the splicing factor Srsf9 is a direct target of both miRNAs during myogenesis. Persistent Srsf9 expression during differentiation impaired myotube formation and blunted induction of the early pro-differentiation factor myogenin as well as the late differentiation marker sarcomeric myosin, Myh8. CONCLUSIONS: Our data uncover novel miR-1 and miR-206 cellular targets and establish a functional link between the splicing factor Srsf9 and myoblast differentiation. The finding that miRNA-mediated clearance of Srsf9 is a key myogenic event illustrates the coordinated and sophisticated interplay between the diverse components of the gene regulatory network. |
format | Online Article Text |
id | pubmed-6888935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68889352019-12-11 miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation Bjorkman, Kristen K. Buvoli, Massimo Pugach, Emily K. Polmear, Michael M. Leinwand, Leslie A. Skelet Muscle Research BACKGROUND: Myogenesis is driven by specific changes in the transcriptome that occur during the different stages of muscle differentiation. In addition to controlled transcriptional transitions, several other post-transcriptional mechanisms direct muscle differentiation. Both alternative splicing and miRNA activity regulate gene expression and production of specialized protein isoforms. Importantly, disruption of either process often results in severe phenotypes as reported for several muscle diseases. Thus, broadening our understanding of the post-transcriptional pathways that operate in muscles will lay the foundation for future therapeutic interventions. METHODS: We employed bioinformatics analysis in concert with the well-established C2C12 cell system for predicting and validating novel miR-1 and miR-206 targets engaged in muscle differentiation. We used reporter gene assays to test direct miRNA targeting and studied C2C12 cells stably expressing one of the cDNA candidates fused to a heterologous, miRNA-resistant 3′ UTR. We monitored effects on differentiation by measuring fusion index, myotube area, and myogenic gene expression during time course differentiation experiments. RESULTS: Gene ontology analysis revealed a strongly enriched set of putative miR-1 and miR-206 targets associated with RNA metabolism. Notably, the expression levels of several candidates decreased during C2C12 differentiation. We discovered that the splicing factor Srsf9 is a direct target of both miRNAs during myogenesis. Persistent Srsf9 expression during differentiation impaired myotube formation and blunted induction of the early pro-differentiation factor myogenin as well as the late differentiation marker sarcomeric myosin, Myh8. CONCLUSIONS: Our data uncover novel miR-1 and miR-206 cellular targets and establish a functional link between the splicing factor Srsf9 and myoblast differentiation. The finding that miRNA-mediated clearance of Srsf9 is a key myogenic event illustrates the coordinated and sophisticated interplay between the diverse components of the gene regulatory network. BioMed Central 2019-12-02 /pmc/articles/PMC6888935/ /pubmed/31791406 http://dx.doi.org/10.1186/s13395-019-0211-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Bjorkman, Kristen K. Buvoli, Massimo Pugach, Emily K. Polmear, Michael M. Leinwand, Leslie A. miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation |
title | miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation |
title_full | miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation |
title_fullStr | miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation |
title_full_unstemmed | miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation |
title_short | miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation |
title_sort | mir-1/206 downregulates splicing factor srsf9 to promote c2c12 differentiation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888935/ https://www.ncbi.nlm.nih.gov/pubmed/31791406 http://dx.doi.org/10.1186/s13395-019-0211-4 |
work_keys_str_mv | AT bjorkmankristenk mir1206downregulatessplicingfactorsrsf9topromotec2c12differentiation AT buvolimassimo mir1206downregulatessplicingfactorsrsf9topromotec2c12differentiation AT pugachemilyk mir1206downregulatessplicingfactorsrsf9topromotec2c12differentiation AT polmearmichaelm mir1206downregulatessplicingfactorsrsf9topromotec2c12differentiation AT leinwandlesliea mir1206downregulatessplicingfactorsrsf9topromotec2c12differentiation |